Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.590
+0.040 (2.58%)
Feb 26, 2026, 2:55 PM EST - Market open
Metagenomi Therapeutics Market Cap
Metagenomi Therapeutics has a market cap or net worth of $59.7 million as of February 26, 2026. Its market cap has decreased by -34.35% in one year.
Market Cap
59.70M
Enterprise Value
-83.31M
1-Year Change
-34.35%
Ranking
Category
Stock Price
$1.59
Market Cap Chart
Since the IPO on February 9, 2024, Metagenomi Therapeutics's market cap has decreased from $562.92M to $59.70M, a decrease of -89.39%. That is a compound annual growth rate of -66.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 58.20M | -4.32% |
| Dec 31, 2025 | 60.83M | -54.98% |
| Dec 31, 2024 | 135.10M | -76.00% |
| Feb 9, 2024 | 562.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Radiopharm Theranostics | 55.07M |
| Tevogen Bio Holdings | 54.93M |
| NovaBay Pharmaceuticals | 54.86M |
| PMV Pharmaceuticals | 54.81M |
| LeonaBio | 54.15M |
| BeyondSpring | 53.05M |
| Nutriband | 52.76M |
| Lipocine | 52.74M |